WELLS FARGO & COMPANY/MN - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXQ and the CUSIP is 686164302. A total of 54 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 8.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$5,000
-80.8%
24,987
+24.1%
0.00%
Q4 2017$26,000
-60.6%
20,129
-35.4%
0.00%
Q3 2017$66,000
-50.0%
31,179
-31.7%
0.00%
Q2 2017$132,000
-13.7%
45,638
+2.5%
0.00%
Q1 2017$153,000
+273.2%
44,538
+89.1%
0.00%
Q4 2016$41,000
-16.3%
23,550
+57.7%
0.00%
Q3 2016$49,00014,9300.00%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 542,755$944,0000.47%
BVF INC/IL 734,976$1,279,0000.26%
Old West Investment Management, LLC 206,018$358,0000.22%
Foresite Capital Management III, LLC 254,257$442,0000.19%
Baupost Group 2,226,839$3,875,0000.05%
Rhenman & Partners Asset Management AB 120,000$209,0000.04%
NEA Management Company, LLC 370,900$645,0000.03%
Rock Springs Capital Management LP 165,300$288,0000.02%
TWO SIGMA SECURITIES, LLC 22,934$40,0000.01%
Telemetry Investments, L.L.C. 10,250$18,0000.01%
View complete list of OREXIGEN THERAPEUTICS INC shareholders